Radiolocalization of Sentinel Lymph Nodes in Clinically N0 Laryngeal and Hypopharyngeal Cancers

Abstract

Objectives:

We sought to analyze the characteristics of radioactive lymph nodes with metastatic disease and to explore methods for the localization of sentinel lymph nodes (SLNs) with radionuclide in clinically N0 laryngeal and hypopharyngeal cancer.

Methods:

Forty-five patients with T1–T4 and clinically N0 laryngeal and hypopharyngeal cancer were recruited. For each patient, a peritumoral submucosal injection of ^99mTc-labeled sulfur colloid was administered, and lymph node mapping was performed by lymphoscintigraphy 2 hours after injection. The SLNs were localized during operation by a handheld gamma probe 10 to 12 hours after the injection, and we defined the radioactive counts from the parotideomasseteric region as background values. All lymph nodes that had accumulated radioactivity were harvested and initially termed as SLNs. Selective neck dissection was performed in all patients. The SLN specimens were sent for formal paraffin–embedded sectioning, serial sectioning, and immunohistochemical assay. The results were compared to those for the remaining lymphadenectomy specimen. Resection of the primary tumor depended on its location and the T classification.

Results:

Sentinel lymph nodes were identified in 41 of 45 patients (51 necks). Sentinel lymph nodes with occult metastases were found in 13 patients (15 necks). In a false-negative case, metastasis was found in a nonsentinel lymph node in 1 of the neck specimens. The SLN identification rate was 92.7%, the sensitivity was 93.7%, the false-negative rate was 6.3%, and the accuracy was 98.0%. In 11 of the 15 necks (73.3%) with pathologically positive SLNs, metastasis was found in the node with the highest radioactivity. Harvesting the first 3 nodes with the highest radioactive counts may identify patients with occult metastatic disease.

Conclusions:

Excision of the first 3 SLNs with the highest radioactive counts can be used to accurately identify the status of cervical lymph node metastases in patients with clinically N0 laryngeal or hypopharyngeal cancer.

Keywords

hypopharyngeal cancer laryngeal cancer radioactive tracer sentinel lymph node biopsy

Get full access to this article

View all access options for this article.

References

Martin

Fey

Yeung

Borgen

Cody

III . Highest isotope count does not predict sentinel node positivity in all breast cancer patients. Ann Surg Oncol 2001;8:592–7.

NCCN (National Comprehensive Cancer Network) Clinical Practice Guidelines in Oncology. Head and Neck Cancers-v.2.2008. www.nccn.org. Accessed May 22, 2008.

Krag

Weaver

Ashikaga

. The sentinel node in breast cancer — A multicenter validation study. N Engl J Med 1998;339:941–6.

Kontio

Leivo

Leppänen

Atula

. Sentinel lymph node biopsy in oral cavity squamous cell carcinoma without clinically evident metastasis. Head Neck 2004;26:16–21.

Tang

Wang

. Selective neck dissection for N0 head and neck carcinoma. Chin J Otorhinolaryngol 1998;33 (suppl):63–7.

Petrovíc

Dordevíc

Nesíc

. Surgical treatment of the supraglottic laryngeal carcinoma. Med Pregl 2008;61:242–6.

Jin

Zheng

Zhou

. Occult cervical lymph node metastasis in 100 consecutive patients with cN0 tongue cancer. Chinese Med J 2008;121:1871–4.

Fletcher

. Subclinical disease. Cancer 1984;53:1274–84.

Chow

Levin

Krivit

Applebaum

. Radiotherapy or surgery for subclinical cervical node metastases. Arch Otolaryngol Head Neck Surg 1989;115:981–4.

10.

Sarno

Bocciolini

Deganello

Coscarelli

Gallo

. Does unnecessary elective neck treatment affect the prognosis of N0 laryngeal cancer patients?. Acta Otolaryngol 2004;124:980–5.

11.

Anan

Mitsuyama

Tamae

. Axillary lymph node metastases in patients with small carcinomas of the breast: Is accurate prediction possible?. Eur J Surg 2000;166:610–5.

12.

Clary

Brady

Lewis

Coit

. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001;233:250–8.

13.

Goldhirsch

Glick

Gelber

Senn

. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst 1998;90:1601–8.

14.

Maffioli

Belli

Gallino

. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck. Tumori 2000;86:341–2.

15.

Eshima

Fauconnier

Eshima

Thornback

. Radiopharmaceuticals for lymphoscintigraphy: Including dosimetry and radiation considerations. Semin Nucl Med 2000;30:25–32.

16.

Yeung

Cody

III Turlakow

. Lymphoscintigraphy and sentinel node localization in breast cancer patients: A comparison between 1-day and 2-day protocols. J Nucl Med 2001;42:420–3.

17.

De Cicco

Cremonesi

Luini

. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998;39:2080–4.

18.

Tomifuji

Shiotani

Fujii

. Sentinel node concept in clinically N0 laryngeal and hypopharyngeal cancer. Ann Surg Oncol 2008;15:2568–75.

19.

Höft

Maune

Muhle

. Sentinel lymph-node biopsy in head and neck cancer. Br J Cancer 2004;91:124–8.

20.

Bourgeois

Nogaret

Veys

. How “hot” is the pathologically positive sentinel lymph node in breast cancer patients?. Nucl Med Commun 2003;24:513–8.

21.

Werner

Dünne

Ramaswamy

. Number and location of radiolabeled, intraoperatively identified sentinel nodes in 48 head and neck cancer patients with clinically staged N0 and N1 neck. Eur Arch Otorhinolaryngol 2002;259:91–6.

22.

Wong

Edwards

Chao

. Sentinel lymph node biopsy for breast cancer: Impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001;192:684–91.